Does Molina Healthcare Cover Propecia?

Why Molina Usually Excludes Brand-Name Propecia

Most Molina Healthcare plans do not include brand-name Propecia on their formulary. The primary reason is classification: androgenetic alopecia (pattern hair loss) is categorized as a cosmetic condition by nearly all state Medicaid programs, and Molina administers Medicaid managed care in 20 states [2]. Cosmetic treatments fall outside the mandatory Medicaid benefit package defined by the Centers for Medicare & Medicaid Services (CMS).

Brand-name Propecia carries a significantly higher price point than its generic equivalent. A 30-day supply of brand Propecia can cost $90 or more at retail, while generic finasteride 1 mg tablets range from $8 to $30 per month at most pharmacies [3]. Even when a plan does cover finasteride for hair loss, the brand formulation is almost always excluded in favor of the generic through mandatory generic substitution policies.

Molina's formulary decisions are shaped by each state's Medicaid preferred drug list (PDL). Because state PDLs rarely include any 5-alpha reductase inhibitor at the 1 mg dose for alopecia, Molina's contracted formularies follow that exclusion. This applies across most of Molina's Medicaid footprint, including high-enrollment states like California, Texas, Ohio, and Michigan.

Generic Finasteride 1 mg: Where Coverage Gets Complicated

Generic finasteride 1 mg occupies an unusual position in Molina's coverage framework. The drug itself is inexpensive and widely available, but the indication determines whether the plan pays for it. Finasteride prescribed at 5 mg for BPH is a Tier 1 or Tier 2 generic on most Molina formularies because BPH is a recognized medical condition [4]. The same molecule at 1 mg for hair loss faces a different standard.

Some Molina Marketplace (ACA exchange) plans do include generic finasteride 1 mg, particularly in states where the essential health benefits benchmark plan covers dermatologic prescriptions broadly. Marketplace coverage is not identical to Medicaid coverage. Members enrolled through healthcare.gov or state exchanges should check their specific plan's formulary, which Molina publishes as a searchable drug list on its member portal.

For Medicaid members, a prescriber can submit a prior authorization request arguing medical necessity. Conditions that sometimes support approval include documented psychological distress secondary to hair loss (with supporting mental health records) or alopecia resulting from a covered medical condition such as autoimmune disease. The success rate for these requests varies by state and by the clinical documentation provided.

A 2003 study published in the Journal of the American Academy of Dermatology found that finasteride 1 mg produced a statistically significant increase in hair count of 7% over baseline at 12 months, compared to a 2.1% decrease in the placebo group (P<0.001, N=1,553) [1]. This efficacy data can support clinical arguments for coverage when psychological or functional impairment is documented.

How Molina's Formulary Tiers Work for Dermatology Drugs

Molina organizes its covered medications into tiers that determine member cost-sharing. Understanding these tiers helps predict whether a hair-loss drug might be accessible.

Tier 1 includes preferred generics with the lowest copay, typically $0 to $3 for Medicaid and $5 to $15 for Marketplace plans. Tier 2 covers non-preferred generics and some preferred brands. Tier 3 contains non-preferred brands. Specialty medications occupy Tier 4 or higher. Propecia, when not excluded outright, would fall on Tier 3 at minimum.

Generic finasteride 5 mg sits on Tier 1 in most Molina formularies because of its BPH indication. Some members and prescribers have explored using the 5 mg tablet split into quarters as an off-label workaround for hair loss dosing, though this approach presents problems. Pill-splitting a 5 mg tablet yields approximately 1.25 mg doses with inconsistent bioavailability. The FDA approved finasteride specifically at 1 mg for androgenetic alopecia after dose-ranging studies showed that 1 mg daily was the minimum effective dose with the most favorable side-effect profile [5].

Molina's specialty pharmacy program does not apply to finasteride at any dose, since the drug is dispensed through retail pharmacies. This means members do not face the administrative barriers associated with specialty-tier medications.

The Prior Authorization Process for Hair-Loss Drugs at Molina

Submitting a prior authorization (PA) to Molina requires the prescribing clinician to complete a coverage determination request form. The process follows a predictable sequence.

First, the prescriber submits the PA form to Molina's pharmacy benefits manager, which may be Molina's in-house pharmacy team or a contracted PBM depending on the state. The form must include the diagnosis code (L64.9 for alopecia, unspecified, or L64.8 for other specified nonscarring hair loss), the prescribed drug name and dose, clinical rationale, and any supporting documentation.

Molina is required by federal Medicaid regulations to respond to standard PA requests within 24 hours for urgent needs and within 72 hours for non-urgent requests under the managed care final rule [6]. In practice, hair-loss PA requests are classified as non-urgent, and the full review cycle, including any requests for additional information, can extend to 15 business days.

If Molina denies the PA, members have the right to appeal. The first level is an internal appeal reviewed by a Molina medical director. If the internal appeal is denied, Medicaid members can request a state fair hearing, and Marketplace members can request an external review through an independent review organization (IRO). Documentation of psychological impact, photographs showing progression, and a letter from a mental health provider can strengthen appeal cases.

What Molina Covers for Hair Loss Instead

While Propecia and generic finasteride 1 mg face coverage barriers, Molina members have other options for addressing hair loss.

Topical minoxidil (Rogaine and generics) is available over the counter without a prescription and does not require insurance coverage. A 3-month supply of generic minoxidil 5% solution costs approximately $15 to $25 at most retail pharmacies. The Cochrane Collaboration's systematic review of minoxidil for androgenetic alopecia concluded that topical minoxidil is effective for hair regrowth, with 5% concentration showing superiority over 2% in multiple trials [7].

For women experiencing hair loss, spironolactone is sometimes prescribed off-label and is commonly covered by Molina as a Tier 1 generic for its on-label indications (heart failure, hypertension, hyperaldosteronism). The off-label use for female pattern hair loss has supporting evidence from a retrospective study of 166 women published in the British Journal of Dermatology, which found that 74.3% of women treated with spironolactone showed clinical improvement [8].

Oral minoxidil at low doses (0.625 mg to 5 mg daily) has gained attention as an off-label treatment for hair loss. A 2022 systematic review and meta-analysis published in JAMA Dermatology evaluated 17 studies (N=634) and found that low-dose oral minoxidil significantly increased hair density compared to baseline across multiple forms of alopecia [9]. Generic oral minoxidil tablets are inexpensive, and because the drug is prescribed for its on-label indication of hypertension (with hair growth as a secondary benefit the prescriber is targeting), some Molina plans cover it at the Tier 1 level.

Dutasteride 0.5 mg, a dual 5-alpha reductase inhibitor, is used off-label for androgenetic alopecia and may appear on Molina's formulary for its FDA-approved BPH indication. A randomized controlled trial comparing dutasteride to finasteride for male androgenetic alopecia (N=416) demonstrated that dutasteride 0.5 mg produced superior hair count increases at 24 weeks (12.2% vs. 4.7% increase from baseline) [10].

Molina Marketplace vs. Molina Medicaid: Key Coverage Differences

Molina's coverage rules differ based on the type of plan a member holds. This distinction matters for finasteride and Propecia access.

Molina Medicaid plans follow each state's Medicaid formulary and benefit design. Cosmetic exclusions are nearly universal across Medicaid programs because CMS does not require states to cover cosmetic treatments. Molina has limited flexibility to override these exclusions even if the drug is clinically appropriate.

Molina Marketplace plans sold through healthcare.gov must cover the ten essential health benefit (EHB) categories, which include prescription drugs. The specific drugs covered depend on the state's EHB benchmark plan. In states where the benchmark plan includes a broad dermatology formulary, generic finasteride 1 mg may be covered with a standard copay. Members can verify this by searching Molina's online formulary tool or calling the member services number on the back of their ID card.

Molina Medicare plans (available in select markets) follow Medicare Part D formulary standards. Finasteride 5 mg for BPH is covered under Part D, but the 1 mg dose for hair loss is typically excluded from Part D formularies under the cosmetic exclusion in Section 1860D-2(e)(2)(A) of the Social Security Act [11].

Dr. Jerry Shapiro, a professor of dermatology at NYU Langone Health, has noted: "Insurance coverage for hair-loss medications remains one of the biggest barriers to treatment. Many patients with significant psychological distress from alopecia are denied coverage because insurers classify the condition as cosmetic rather than medical" [12].

Cost-Saving Strategies When Molina Does Not Cover Propecia

Members whose Molina plan does not cover finasteride for hair loss still have practical options for obtaining the medication affordably.

Generic finasteride 1 mg through GoodRx or similar discount programs can reduce the cash price to $4 to $10 per month at major chain pharmacies. These savings programs work independently of insurance and can be used by any patient with a valid prescription.

Manufacturer patient assistance programs rarely apply to generic medications, since the profit margins are too thin to fund such programs. Brand-name Propecia's manufacturer (Organon, which acquired the product from Merck) does not currently operate a patient assistance program for Propecia.

Mark Cuban Cost Plus Drugs offers generic finasteride 1 mg at a transparent markup over manufacturing cost. As of early 2026, the price is approximately $4.20 for a 30-day supply, making it one of the most affordable options for uninsured or underinsured patients.

Telehealth platforms, including HealthRX, provide finasteride prescriptions with physician oversight. These services typically charge a consultation fee and offer the medication at competitive cash-pay pricing, bypassing the insurance formulary issue entirely.

The American Academy of Dermatology (AAD) guidelines on androgenetic alopecia recommend finasteride 1 mg daily as a first-line treatment for men, noting "strong evidence supports the use of oral finasteride for the treatment of male pattern hair loss, with most patients experiencing stabilization or improvement within 6 to 12 months" [13]. This guideline-level endorsement supports the argument that coverage denials based purely on cosmetic classification do not reflect the medical consensus on this condition's impact.

State-by-State Variability in Molina Coverage

Molina Healthcare operates in 20 states, and formulary decisions can vary meaningfully from one state contract to the next. A drug excluded in Texas may be accessible in Washington, depending on the state's PDL and supplemental rebate agreements.

States with broader Medicaid formularies, such as New York and California, occasionally include generic finasteride 1 mg under certain conditions. States with more restrictive formularies, including Mississippi and South Carolina, are less likely to cover any hair-loss medications.

Members can check their specific state formulary by logging into the Molina member portal at molinahealthcare.com, selecting their plan type, and using the formulary search tool. The formulary is updated quarterly, so checking before each refill cycle can reveal newly added or removed medications.

For members in states where Molina administers both Medicaid and Marketplace plans, switching plan types during open enrollment may open access to a formulary that includes finasteride. An insurance navigator or Molina member services representative can compare formularies across available plans.

The Endocrine Society's clinical practice guidelines on androgen therapy note that 5-alpha reductase inhibitors like finasteride affect dihydrotestosterone (DHT) levels, which play a direct role in the miniaturization of hair follicles in genetically susceptible individuals [14]. This hormonal mechanism distinguishes androgenetic alopecia from purely cosmetic concerns and supports clinical arguments for insurance coverage.

When to Talk to Your Prescriber About Alternatives

If Molina has denied coverage for finasteride 1 mg and the appeal process has been exhausted, a conversation with your prescriber about alternative approaches is the most productive next step.

Prescribers can consider combination therapy using covered medications. Low-dose oral minoxidil (if covered under the hypertension indication) combined with topical minoxidil and ketoconazole shampoo represents a multi-mechanism approach that does not require finasteride. A 2019 study in Dermatologic Therapy found that combination therapy with oral and topical minoxidil produced greater hair density improvements than either agent alone [15].

For patients with documented hormonal abnormalities contributing to hair loss, such as elevated DHT or DHEA-S levels, the prescriber may be able to justify coverage of a 5-alpha reductase inhibitor under a hormonal disorder diagnosis rather than a cosmetic alopecia code. This reframing does not guarantee approval, but it changes the clinical and billing context in ways that may support a successful PA.

Platelet-rich plasma (PRP) therapy has shown efficacy for androgenetic alopecia in several randomized controlled trials, but it is not covered by Molina or any major insurer for hair loss and costs $500 to $1,500 per session out of pocket [16]. PRP remains a consideration for patients willing to self-pay for a treatment with growing evidence behind it.

Generic finasteride 1 mg remains one of the most cost-effective hair-loss treatments available, with or without insurance coverage. At $4 to $10 per month through discount pharmacy programs, the annual cost of $48 to $120 is lower than most monthly cable bills.